Lucas Arruda

Chief Scientific Officer at CuraCell

Speaker

Dr. Arruda is a cancer immunotherapy specialist with expertise in TCR-T, TILs, CAR-T, and bispecific antibodies. His work focuses on developing next-generation cell and antibody-based therapies, with particular emphasis on TILs, T-cell and NK-cell engagers for solid and hematologic malignancies. He has a strong background in immune profiling and translational research, applying advanced technologies such as flow cytometry, next-generation sequencing, and single-cell analysis to accelerate the development of personalized immunotherapies.